Shortage Watch Free FDA drug-shortage watch

← all medications

Vigabatrin Oral Solution

Category: Neurology

Not specified 1

FDA status: To Be Discontinued · Last FDA update: Oct 16, 2025 · First posted: Oct 16, 2025 · 1 manufacturers, 1 listed presentations

As of Oct 16, 2025, the FDA lists Vigabatrin Oral Solution as being discontinued. Of 1 manufacturer presentations, 1 Not specified.

Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Vigabatrin Oral Solution is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.
Presentation & package NDCManufacturerAvailabilityFDA note
Vigpoder, Oral Solution, 50 mg/1 mL (NDC 80789-117-50)
NDC 80789-117-50
Pyros Pharmaceuticals, Inc. Not specified Discontinuation of the manufacture of the drug

Related medications in shortage

Other Neurology medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Vigabatrin Oral Solution (FDA data as of Oct 16, 2025). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Vigabatrin Oral Solution. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Vigabatrin Oral Solution.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/vigabatrin-oral-solution.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).